Risankizumab for treating moderate to severe plaque psoriasis

Equality Impact Assessment (Guidance development) (PDF 157 KB)

Final draft guidance

Final appraisal document (PDF 235 KB)

Committee papers (PDF 4.32 MB)

Public committee slides (PDF 1.1 MB)

Final scope (PDF 273 KB)

Final matrix (PDF 257 KB)

Equality impact assessment (Scoping) (PDF 177 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 339 KB)

Draft scope pre referral (PDF 288 KB)

Draft matrix pre referral (PDF 257 KB)